16
Oversold
Moving averages
SMA 200$0.18-99.94%
Company profile
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company is headquartered in Weston, Florida.
SectorHealthcare
IndustryBiotechnology
Market cap$1.54M
P/E ratioNone
EPS$-4.18
Beta0.791
Dividend yield0.00%
52-week high$0.80
52-week low$0.11
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
ARTL
Artelo Biosciences Inc
RSI 26
VRAX
Virax Biolabs Group Ltd - Class A
RSI 19
IMNN
Imunon Inc
RSI 25
ACXP
Acurx Pharmaceuticals Inc
RSI 45
SKYE
Skye Bioscience Inc
RSI 32
SNGX
Soligenix Inc
RSI 21
RSI alerts for ZVSA
An email when ZVSA closes below RSI 30 or above 70. Nothing else.
Data last updated 23 October 2026 at 1:03 AM EDT